Omni Hand leverages optical sensors to capture minute changes in tissue light transmittance caused by the movement of muscles and tendons
Motorica, a global MedTech company specialising in assistive technologies and medical cybernetics, has unveiled Omni Hand, world’s first bionic hand prosthesis equipped with optical myography (OMG) sensors. The launch marks a major leap forward in human–technology interaction and intuitive prosthetic control.
Moving beyond the limitations of traditional muscle-signal prosthetics, the Omni Hand leverages optical sensors to capture minute changes in tissue light transmittance caused by the movement of muscles and tendons. By interpreting these subtle variations in real time, the prosthesis translates even the smallest impulses into natural, precise motion. This breakthrough extends the benefits of advanced prosthetics to individuals with limited muscle activity, such as those recovering from electrical injuries, frostbite, or trauma, making intuitive and responsive control accessible to a wider spectrum of users.
“Omni Hand represents a new level of human-technology interaction. It doesn’t just respond to movement, it understands the user’s intent. This is a step toward truly natural control of bionic prosthetics,” said Andrei Davidiuk, CEO, Motorica.
The prosthesis is designed to recognize a set of the user’s “phantom gestures”, movements the brain imagines making with the missing hand, such as clenching a fist, making a pinch, or pointing. The Omni Hand can recognise and execute up to six individual gestures without the need to switch modes, ensuring fast, effortless, and adaptive control. Powered by an advanced user decision support system, the technology continuously learns from each interaction, adapting to the individual’s control patterns and improving precision over time, effectively enabling the prosthesis to evolve alongside the user.
While optical sensing in prosthetics has long remained within the realm of research, Cyber Motorica has become the first company to translate this breakthrough into real-world use. The successful pilot rollout, with the first eight users already integrating Omni Hand into their daily lives, marks a significant step forward in practical adoption and user experience. With mass production planned for 2026, the company is poised to make advanced, intuitive prosthetic control accessible to users on a global scale.
